Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer have?
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer has 308 citations in the OpenAlex counts ScholarIQ stores.
When was Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer published?
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer has 2018 year in the ScholarIQ index.
What is the open-access status of Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer?
Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer?
The DOI for Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer is on the source record.
What is the PMID of Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer?
The PMID for Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer is on the source record.
What is the OpenAlex record for Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer?
The OpenAlex for Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer is on the source record.